Yildirim C, Kutluhan MA, Sahin A, Topakta R, Urkmez A. Three different urogenital carcinoma in an aging patient: a rare case presentation. Aging Male. 2020;23(5):911–3.
John A, Spain L, Hamid AA. Navigating the current Landscape of Non-clear Cell Renal Cell Carcinoma: a review of the literature. Curr Oncol. 2023;30(1):923–37.
Article PubMed PubMed Central Google Scholar
Meng J, Gao L, Zhang M, Gao S, Fan S, Liang C. Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients. Biomark Med. 2020;14(3):223–38.
Article CAS PubMed Google Scholar
You B, Sun Y, Luo J, Wang K, Liu Q, Fang R, Liu B, Chou F, Wang R, Meng J, et al. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene. 2021;40(9):1674–89.
Article CAS PubMed PubMed Central Google Scholar
Bian Z, Meng J, Niu Q, Jin X, Wang J, Feng X, Che H, Zhou J, Zhang L, Zhang M, et al. Prognostic role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin ratio, platelets, sex, and Fibrinogen in Predicting recurrence-free Survival Time of Renal Cancer. Cancer Manag Res. 2020;12:8481–90.
Article CAS PubMed PubMed Central Google Scholar
Chida K, Oshi M, Roy AM, Sato T, Endo I, Takabe K. Pancreatic ductal adenocarcinoma with a high expression of alcohol dehydrogenase 1B is associated with less aggressive features and a favorable prognosis. Am J Cancer Res. 2023;13(8):3638–49.
CAS PubMed PubMed Central Google Scholar
Lee DW, Ji YB, Song CM, Kim JK, Lee SH, Tae K. Impact of Alcohol dehydrogenase 7 polymorphism and alcohol consumption on risk of Head and Neck squamous cell carcinoma: a Korean case-control study. J Clin Med 2023, 12(14).
Du Q, Liu S, Dong K, Cui X, Luo J, Geller DA. Downregulation of iNOS/NO promotes epithelial-mesenchymal transition and metastasis in Colorectal Cancer. Mol Cancer Res. 2023;21(2):102–14.
Article CAS PubMed Google Scholar
Kasamatsu S, Nishimura A, Alam MM, Morita M, Shimoda K, Matsunaga T, Jung M, Ogata S, Barayeu U, Ida T, et al. Supersulfide catalysis for nitric oxide and aldehyde metabolism. Sci Adv. 2023;9(33):eadg8631.
Article PubMed PubMed Central Google Scholar
Cañas A, López-Sánchez LM, Peñarando J, Valverde A, Conde F, Hernández V, Fuentes E, López-Pedrera C, de la Haba-Rodríguez JR, Aranda E, et al. Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab. Biochim Biophys Acta. 2016;1862(4):601–10.
Al-Refai R, Bendari A, Morrar D, Sham S, Kataw L, Garajayev A, Hajiyeva S. Immunohistochemical Staining Characteristics of Low-Grade Invasive Ductal Carcinoma Using the ADH5 Cocktail (CK5/14, P63, and CK7/18): A Potential Interpretative Pitfall. Diagnostics (Basel) 2023, 13(18).
Zhang Y, Zhang R, Liang F, Zhang L, Liang X. Identification of Metabolism-Associated prostate Cancer subtypes and Construction of a prognostic risk model. Front Oncol. 2020;10:598801.
Article PubMed PubMed Central Google Scholar
Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–92.
Article CAS PubMed Google Scholar
Wang Y, Cong R, Liu S, Zhu B, Wang X, Xing Q. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma. Cancer Cell Int. 2021;21(1):46.
Article CAS PubMed PubMed Central Google Scholar
Luo Y, Shen D, Chen L, Wang G, Liu X, Qian K, Xiao Y, Wang X, Ju L. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Aging. 2019;11(16):6029–52.
Article CAS PubMed PubMed Central Google Scholar
Guo Y, Wu Z, Cen K, Bai Y, Dai Y, Mai Y, Hong K, Qu L. Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma. Front Immunol. 2023;14:1171811.
Article CAS PubMed PubMed Central Google Scholar
Zhai W, Chen S, Duan F, Wang J, Zhao Z, Lin Y, Rao B, Wang Y, Zheng L, Long H. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Cancer Med 2022.
Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–46.
Article CAS PubMed Google Scholar
Yu Z, Lv Y, Su C, Lu W, Zhang R, Li J, Guo B, Yan H, Liu D, Yang Z, et al. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma. Cancer Res. 2023;83(5):700–19.
Article CAS PubMed PubMed Central Google Scholar
Feurstein S. Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle. Front Oncol. 2023;13:1128533.
Article CAS PubMed PubMed Central Google Scholar
Liu Q, Gu T, Su LY, Jiao L, Qiao X, Xu M, Xie T, Yang LX, Yu D, Xu L, et al. GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation. Redox Biol. 2021;47:102172.
Article CAS PubMed PubMed Central Google Scholar
Chiang CP, Jao SW, Lee SP, Chen PC, Chung CC, Lee SL, Nieh S, Yin SJ. Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer. Alcohol. 2012;46(1):37–49.
Article CAS PubMed Google Scholar
Tang CH, Wei W, Liu L. Regulation of DNA repair by S-nitrosylation. Biochim Biophys Acta. 2012;1820(6):730–5.
Article CAS PubMed Google Scholar
Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.
Article CAS PubMed PubMed Central Google Scholar
Alam J, Huda MN, Tackett AJ, Miah S. Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. Cancer Metastasis Rev. 2023;42(2):409–25.
Article CAS PubMed PubMed Central Google Scholar
Massagué J, Sheppard D. TGF-β signaling in health and disease. Cell. 2023;186(19):4007–37.
Article PubMed PubMed Central Google Scholar
Ke J, Chen J, Liu X. Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma. Anim Cells Syst (Seoul). 2022;26(2):52–61.
Article CAS PubMed Google Scholar
Cao H, Zhang J, Wang W. DAB2IP plays important clinical significance and correlates with Immune Infiltration in Renal Cell Carcinoma. Technol Cancer Res Treat. 2020;19:1533033820936682.
Article CAS PubMed PubMed Central Google Scholar
Krishna C, DiNatale RG, Kuo F, Srivastava RM, Vuong L, Chowell D, Gupta S, Vanderbilt C, Purohit TA, Liu M, et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021;39(5):662–e677666.
Article CAS PubMed PubMed Central Google Scholar
Stenzel PJ, Schindeldecker M, Tagscherer KE, Foersch S, Herpel E, Hohenfellner M, Hatiboglu G, Alt J, Thomas C, Haferkamp A, et al. Prognostic and predictive value of Tumor-infiltrating leukocytes and of Immune Checkpoint molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma. Transl Oncol. 2020;13(2):336–45.
Yeh CR, Ou ZY, Xiao GQ, Guancial E, Yeh S. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals. Oncotarget. 2015;6(42):44346–59.
Article PubMed PubMed Central Google Scholar
Ou Z, Wang Y, Chen J, Tao L, Zuo L, Sahasrabudhe D, Joseph J, Wang L, Yeh S. Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals. Exp Mol Med. 2018;50(11):1–11.
Zhang C, Li Z, Qi F, Hu X, Luo J. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma. Ann Transl Med. 2019;7(22):648.
Article CAS PubMed PubMed Central Google Scholar
Kanannejad Z, Soleimanian S, Ghahramani Z, Sepahi N, Mohkam M, Alyasin S, Kheshtchin N. Immune checkpoint molecules in prevention and development of asthma. Front Immunol. 2023;14:1070779.
Article CAS PubMed PubMed Central Google Scholar
Moon SY, Han M, Ryu G, Shin SA, Lee JH, Lee CS. Emerging Immune Checkpoint molecules on Cancer cells: CD24 and CD200. Int J Mol Sci 2023, 24(20).
Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.
Comments (0)